The Latest Cardiac and Vascular News
Fourth-quarter highlights Group sales amounted to EUR 4.9 billion, with a 10% comparable sales decline Comparable order intake increased 4%, driven by double-digit growth in the Diagnosis & Treatment businesses Income from continuing operations amounted to EUR 139 million and included an impact of EUR 220 million related to the […]
Ghent, Belgium – 21 January 2022 – Sequana Medical NV (Euronext Brussels: SEQUA, the “Company” or “Sequana Medical”), an innovator in the treatment of diuretic-resistant fluid overload in liver disease, malignant ascites and heart failure, announces in accordance with Article 15 of the Belgian Act of 2 May 2007 on […]
Oak Ridge, TN, Jan. 21, 2022 (GLOBE NEWSWIRE) — Daxor Corporation (NYSE: DXR), the global leader in blood volume measurement technology, announced today that it has appointed Caleb DesRosiers, JD, MPA to its Board of Directors, effective January 18, 2022. Mr. DesRosiers is currently a Senior Principal at Valuate Healthcare Consultancy, a leading […]
Casana’s Series B led by Morningside. Matrix Partners and Series A investors General Catalyst and Outsiders Fund join the round. The Heart Seat, an effortless, patient-centered health monitoring technology built into a toilet seat, is Casana’s first product. ROCHESTER, N.Y., Jan. 21, 2022 (GLOBE NEWSWIRE) — Casana, a healthcare technology […]
Camardo to lead Company’s transition to a commercial-stage company CLEVELAND–(BUSINESS WIRE)–Athersys, Inc. (Nasdaq: ATHX), an international, late-stage, regenerative medicine company, announced today the appointment of Daniel A. Camardo as the Company’s Chief Executive Officer, effective February 14, 2022. Mr. Camardo is a senior pharmaceutical and biotech executive with more than […]
CARLSBAD, Calif., Jan. 19, 2022 (GLOBE NEWSWIRE) — Acutus Medical, Inc. (“Acutus” or the “Company”) (Nasdaq: AFIB), an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and treated, today announced a corporate restructuring as well as its preliminary unaudited revenue for the quarter and full year […]
MENLO PARK, Calif., Jan. 18, 2022 /PRNewswire/ — Ajax Health has announced the appointments of two of the most respected cardiovascular professionals to Cordis-X, an independent accelerator created to drive innovation and growth to Cordis. Cordis is a storied medical device brand with global reach that was acquired from Cardinal Health last […]
REDWOOD CITY, Calif., Jan. 18, 2022 (GLOBE NEWSWIRE) — HeartFlow Holding, Inc., the leader in revolutionizing precision heart care, today announced the appointment of Timothy Barabe to its Board of Directors. “We are honored to have an accomplished leader like Tim join the HeartFlow Board,” said William C. Weldon, Chairman of […]
Artivion to Host Investor & Analyst Day on March 23, 2022 ATLANTA, Jan. 18, 2022 /PRNewswire/ — CryoLife, Inc. (NYSE: CRY), a leading cardiac and vascular surgery company focused on aortic disease, announced today that it was renaming and rebranding itself to Artivion, Inc., effective immediately. Derived from the words “aorta”, “innovation”, and […]
Preliminary Full Year 2021 Product Sales were approximately $40.1 million, including core non-COVID-19 sales growth of approximately 13% from 2020. Cumulative CytoSorb treatments surpassed 162,000. MONMOUTH JUNCTION, N.J., Jan. 18, 2022 /PRNewswire/ — CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery using blood […]
